The tumor suppressor protein, p53, mutated in about 50% of human cancers53 was reported to gain new oncogenic functions such as chemoresistance to commonly used anticancer drugs, enhanced cell growth, metabolism and invasion54, 55 and, promoting the removal of mutant p53 might have therapeutic relevance in cancer cells. This evidence concerns the gene TP53 and cancer.